Items where authors include "Salmenniemi, U."
Article
Robin, M. orcid.org/0000-0003-1388-9876, Iacobelli, S., Koster, L. et al. (22 more authors) (2024) Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation. ISSN 0268-3369
Chalandon, Y. orcid.org/0000-0001-9341-8104, Sbianchi, G., Gras, L. et al. (22 more authors) (2023) Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT. American Journal of Hematology, 98 (1). pp. 112-121. ISSN 0361-8609
Duque-Afonso, J., Finke, J., Labopin, M. et al. (18 more authors) (2022) Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplantation, 57 (8). pp. 1269-1276. ISSN 0268-3369
Proceedings Paper
Garderet, L., Gras, L., Koster, L. et al. (22 more authors) (2023) Long term outcomes and renal response following autologous stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Cmwp of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 3403.
Robin, M., Iacobelli, S., Passweg, J.R. et al. (22 more authors) (2023) Treosulfan vompared to Busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the chronic malignancies working party of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 473.